Tiago Girao insider trades: Immunovant (IMVT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tiago reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | IMVT | ↓ Sell | 6,606 | $28.50 | $188K | Direct | Oct 30, 2026 (2d) |
| Jul 23, 2026 | IMVT | ↓ Sell | 6,798 | $38.69 | $263K | Direct | Jul 24, 2026 (1d) |
| Jun 26, 2026 | IMVT | ↓ Sell | 10,000 | $38.46 | $385K | Direct | Jun 26, 2026 (0d) |
| Aug 18, 2015 | CYTX | ↑ Buy | 25,000 | $0.39 | $10K | Direct | Aug 19, 2015 (1d) |
| Nov 12, 2014 | CYTX | ↑ Buy | 60,000 | $0.39 | $23K | Direct | Nov 12, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMVT insiders
Open-market trades in the last 12 months
About Tiago Girao's insider trades
Tiago Girao is Chief Financial Officer at Immunovant (IMVT). Since Nov 12, 2014, Tiago has reported 2 open-market purchases worth $33K and 3 sales worth $836K on SEC Form 4. In the last 12 months: 3 sales ($836K).
Their filings also include grants and awards (11 filings), option exercises (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMVT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.